Gregory J Divis
CIK 1410677 · Chief Executive Officer · last filed 2026-02-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$32.6K
Companies
3
Total Filings
31
Lifetime Open-Market Net
$727.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Chief Executive Officer | 0 | $21.64 | $0 | $727.6K | 17 | 2026-02-12 |
| JAGX | Director | 12,133 | $2.69 | $32.6K | $0 | 6 | 2022-05-18 |
| K-V Pharmaceutical Co (KV.B) Delisted | CEO and President | 1,225 | — | — | $0 | 6 | 2012-03-30 |
Recent Filings · Page 3 of 4
31 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-03-23 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-12-14 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Grant (A) | +22,500 | $0 | EDGAR |
| 2017-09-14 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Buy (P) | +10,600 | $98.8K | EDGAR |
| 2013-10-04 | — | Grant (A) | — | $0 | |
| 2013-09-18 | — | Other (J) | −1,225 | $0 | |
| 2012-03-30 | K-V Pharmaceutical Co (KV.B) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-09-12 | K-V Pharmaceutical Co (KV.B) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-09-09 | K-V Pharmaceutical Co (KV.B) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-04-29 | K-V Pharmaceutical Co (KV.B) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-01-15 | K-V Pharmaceutical Co (KV.B) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.